- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05038033
Addressing Anxiety and Stress for Healthier Eating in Teens (ASSET)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Natalia Sanchez, MPH
- Phone Number: 970-491-1120
- Email: natalia.sanchez@colostate.edu
Study Contact Backup
- Name: Alexander Rice, PhD
- Phone Number: 310-845-5058
- Email: alexander.rice.ctr@usuhs.edu
Study Locations
-
-
Colorado
-
Fort Collins, Colorado, United States, 80523-1570
- Recruiting
- Colorado State University
-
Contact:
- Natalia Sanchez
- Phone Number: 970-491-1120
- Email: Natalia.Sanchez@colostate.edu
-
Principal Investigator:
- Lauren Shomaker, PhD
-
-
Maryland
-
Bethesda, Maryland, United States, 20814
- Recruiting
- Uniformed Services University
-
Contact:
- Alexander Rice, PhD
- Phone Number: 310-845-5058
- Email: alexander.rice.ctr@usuhs.edu
-
Contact:
- Julia Gallagher-Teske, BS
- Phone Number: 301-400-4401
- Email: julia.gallagher-teske.ctr@usuhs.edu
-
Principal Investigator:
- Mairan Tanofsky-Kraff, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Participant Inclusion Criteria:
- 12-17-year-old adolescent girls
- BMI ≥ 75th percentile
- Anxiety symptoms: 32 or higher on State Trait Anxiety Inventory for Children-Trait Scale
Participant Exclusion Criteria:
- Any medical condition (as well as pregnancy or breastfeeding)
- Individuals who have any DSM psychiatric disorder that, in the opinion of the investigators, would impede competence or compliance or possibly hinder completion of the study
- Medication impacting mood or weight
- Psychotherapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Interpersonal Psychotherapy (IPT)
Interpersonal Psychotherapy program adapted for the prevention of excessive weight gain.
Involves one initial 1.5-hour individual session, and 12 weekly 90-minute group sessions.
|
The IPT group sessions follow three phases (initial, middle, and termination) and use the interpersonal inventory to identify interpersonal problems that might be contributing to or exacerbating disinhibited eating and anxiety symptoms.
A framework of common problem areas is used to teach interpersonal problem-solving and communication skills and educate youth about risk factors and warning signs for excessive weight gain, such as eating in response to negative affect as opposed to hunger, or feeling a sense of loss-of-control while eating.
IPT focuses on psychoeducation and general skill-building that can be applied to different relationships within the framework of four interpersonal problem areas: interpersonal role disputes, role transitions, interpersonal deficits, and grief.
|
|
Active Comparator: Cognitive-Behavioral Therapy (CBT)
The CBT program will match the delivery format and dose of the IPT program.
There will be one initial 1.5-hour individual session, and 12 weekly 90-minute group sessions.
|
The CBT program will be derived from Coping Cat, a manualized intervention for children and adolescents with elevated symptoms of anxiety.
The group intervention builds skills for managing anxiety, in general, but with a focus on how anxiety prompts disinhibited eating, including attention to and restructuring of negative cognitions that perpetuate anxiety and behavioral exposure, rather than avoidance, of anxiety-provoking situations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention Fidelity and Acceptability
Time Frame: Entirety of the Study
|
Feasibility: Fidelity ratings of facilitators' competence/adherence in administration of IPT and CBT; CONSORT tracking of recruitment, recruitment rate and percentage of eligible adolescents who enroll as recorded by study coordinators; median sessions attended and home practice completion, as recorded by facilitators; CONSORT tracking of follow-up retention as recorded by study coordinators; and completeness of data collection. Acceptability: Adolescent self-reports on program and monitor acceptability questionnaires |
Entirety of the Study
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Presence of Disinhibited Eating
Time Frame: Post-Treatment
|
Eating Disorder Examination Interview- overeating section will be administered to assess for the presence of overeating with and without loss of control.
|
Post-Treatment
|
|
Mood/Anxiety, Eating, And Social Functioning
Time Frame: Post Treatment
|
Adolescent self-reports on mood and eating as well as psychological distress via questionnaire, interview, and smartphone surveys. Assesed through completion of surveys: Center For Epidemiologic Studies - Depression Scale (CES-D), Social Phobia And Anxiety Inventory For Children (SPAI-C), Emotional Eating Scale - Children, Social Adjustment Scale-self Report, Difficulties In Emotion Regulation Scale-short Form, Conflict Behavior Questionnaire, Network Of Relationships Inventory-short Form, Children's Automatic Thoughts Scale (CATS-N/P), Anxiety Control Questionnaire For Children (ACQ-C), The Self-efficacy Questionnaire For Children (SEQ-C), Children's Coping Strategies Checklist - Revised (CCSC-R1), Positive And Negative Affect Schedule - Child Form (PANAS-C). |
Post Treatment
|
|
Participant Height, Weight, and Blood Pressure
Time Frame: Post Treatment
|
Weight will be measured via scale and height via stadiometer.
This will be used to calculate BMI percentile.
Blood pressure assessed via digital blood pressure monitor.
|
Post Treatment
|
|
Body Composition Measurement
Time Frame: Post treatment
|
Assessed using air displacement plethysmography (Bod Pod).
|
Post treatment
|
|
Collection of Metabolic Markers
Time Frame: Post Treatment
|
Blood will be drawn in a fasted state to measure glucose, insulin, and lipids.
|
Post Treatment
|
|
Parental report of eating behaviors
Time Frame: Post Treatment
|
Parents/guardians will be asked to complete Eating in the Absence of Hunger Questionnaire for Children - Parent Report (EAH-C Parent).
|
Post Treatment
|
|
Cardiometabolic Functioning
Time Frame: Post Treatment
|
Measured by blood draw, continuous glucose monitoring, and heart rate, sleep and activity via Carnation Ambulatory Monitor.
|
Post Treatment
|
|
Movement and Activity
Time Frame: Post Treatment
|
Measured by ActivPal monitoring device
|
Post Treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- USUHS.2020-048
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorders
-
Kansas State UniversityAugusta University; Dartmouth College; University of CincinnatiEnrolling by invitationMental Disorders, Severe | Mental Illness PersistentUnited States
-
Rutgers, The State University of New JerseyRecruiting
-
Virginia Commonwealth UniversityCompletedMental Health DisordersUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMental Health DisordersCongo
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedMental Health DisordersNorway
-
York UniversityCanadian Institutes of Health Research (CIHR); North York General HospitalCompletedMental Health DisordersCanada
-
VA Boston Healthcare SystemUS Department of Veterans AffairsCompletedMental Health DisordersUnited States
-
Mindstate Design LabsCompleted
-
University of HaifaCompletedMental Health DisordersIsrael
-
University of ManchesterEuropean Research CouncilRecruitingMental Disorders, SevereUnited Kingdom
Clinical Trials on Interpersonal Psychotherapy (IPT)
-
University of IowaNational Institute of Mental Health (NIMH)Completed
-
University of MichiganNational Institute of Mental Health (NIMH)CompletedDepression | Anxiety DisordersUnited States
-
Pakistan Institute of Living and LearningCompleted
-
University of RochesterNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
New York State Psychiatric InstituteCompleted
-
Hospital de Clinicas de Porto AlegreTerminated
-
University of PittsburghNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
New York State Psychiatric InstituteCompleted
-
Linkoeping UniversityVästernorrland County Council, Sweden; REHSAM; Psychiatric clinic, Hospital of...UnknownShort Term Therapy for Outpatients Diagnosed With Major Depressive DisorderSweden
-
University of PittsburghCarnegie Mellon UniversityCompletedMajor Depressive DisorderUnited States